Journal: Molecular cell

Article Title: The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcoma

doi: 10.1016/j.molcel.2022.03.019

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Mesenchymal Stem Cell Growth Kit for Adipose and Umbilical-derived MSCs - Low Serum , ATCC , Cat# PCS-500-040.

Techniques: Microarray, Recombinant, Sample Purification, Isolation, Derivative Assay, shRNA, Construct, CRISPR, Plasmid Preparation, Software

Journal: Molecular cell

Article Title: The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcoma

doi: 10.1016/j.molcel.2022.03.019

Figure Lengend Snippet: A. Experimental schematic to profile BAF complex localization and other chromatin changes in hTERT-MSCs upon 24 hours adipogenesis. B. edgeR analysis of differential occupancy of BAF complexes (SMARCA4) on the genome upon 24 hours adipogenesis. C. HOMER motif analysis of sites that gain BAF complex (SMARCA4) occupancy upon 24 hours adipogenesis. D. Heatmap of SMARCA4, CEBPB, H3K27ac, and ATAC-seq peaks over sites that gain BAF complex (SMARCA4) occupancy upon 24 hours adipogenesis (“SMARCA4 targets”). E. Experimental schematic to define the specific role for BAF complexes in adipogenesis using small molecule-mediated inhibition of BAF complex ATPase activity with compound 12 (CMP12). F. Heatmap of SMARCA4, CEBPB, H3K27ac, and ATAC-seq peaks upon DMSO or CMP12 treatment in base or adipogenic media for 24 hours over SMARCA4 gained sites in the DMSO adipogenesis condition. G. Comparison of changes in RNA in the CMP12 and DMSO treatment conditions upon adipogenesis. Dark blue circles are genes that are not as up-regulated or are more down-regulated upon adipogenesis with CMP12 treatment compared to DMSO (CMP12-attenuated gene). Light blue circles are a subset of CMP12-attenuated genes that are also nearest to sites that gain BAF complexes (SMARCA4) upon adipogenesis in the DMSO condition (CMP12-attenuated gene and SMARCA4 target). H. Gene ontology analysis of CMP12-attenuated gene and SMARCA4 targets. I. Heatmap of logFC in expression of genes in DMSO and CMP12 conditions upon adipogenesis. J. Track examples at the CD36, ELOVL6 and WNT5A loci. See also Figure S4.

Article Snippet: Mesenchymal Stem Cell Growth Kit for Adipose and Umbilical-derived MSCs - Low Serum , ATCC , Cat# PCS-500-040.

Techniques: Inhibition, Activity Assay, Comparison, Expressing

Journal: Molecular cell

Article Title: The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcoma

doi: 10.1016/j.molcel.2022.03.019

Figure Lengend Snippet: KEY RESOURCES TABLE

Article Snippet: Mesenchymal Stem Cell Growth Kit for Adipose and Umbilical-derived MSCs - Low Serum , ATCC , Cat# PCS-500-040.

Techniques: Microarray, Recombinant, Sample Purification, Isolation, Derivative Assay, shRNA, Construct, CRISPR, Plasmid Preparation, Software

Journal: Reproductive Biology and Endocrinology : RB&E

Article Title: A promising future for endometriosis diagnosis and therapy: extracellular vesicles - a systematic review

doi: 10.1186/s12958-022-01040-y

Figure Lengend Snippet: Key characteristics of studies of extracellular vesicles in endometriosis

Article Snippet: Shan 2021 [ ] , Human ( n = 5 for RNA seq, n = 80 for validation) , Human ( n = 6 for RNA seq, n = 80 for validation) , Serum , ExoRNeasy Serum/Plasma Midi Kit (#76,214, Qiagen) , Yes , lncRNAs (seq) Ten lncRNAs validated with RT-qPCR , Potential diagnostic marker RP3-399L15.2 AUC 0.86, Sn 67%, Sp 98%. Using combination of RP3-399L15.2 and CH507-513H4.6 AUC 0.90, Sn 80%, Sp 85%. , Not discussed, but potential therapeutic targets , Not discussed , Endometriomas only.

Techniques: Diagnostic Assay, Isolation, Derivative Assay, Migration, Biomarker Discovery, Activity Assay, Inhibition, Expressing, Over Expression, Clinical Proteomics, Control, RNA Sequencing, Marker, In Vivo, In Vitro, Microarray, Cell Culture